IL291827A - Zinc finger protein transcription factors to suppress alpha-synuclein expression - Google Patents
Zinc finger protein transcription factors to suppress alpha-synuclein expressionInfo
- Publication number
- IL291827A IL291827A IL291827A IL29182722A IL291827A IL 291827 A IL291827 A IL 291827A IL 291827 A IL291827 A IL 291827A IL 29182722 A IL29182722 A IL 29182722A IL 291827 A IL291827 A IL 291827A
- Authority
- IL
- Israel
- Prior art keywords
- repressing
- alpha
- zinc finger
- transcription factors
- finger protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
- C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14041—Use of virus, viral particle or viral elements as a vector
- C12N2750/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14071—Demonstrated in vivo effect
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Psychology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962909496P | 2019-10-02 | 2019-10-02 | |
| US202062959153P | 2020-01-09 | 2020-01-09 | |
| PCT/US2020/054148 WO2021067871A1 (en) | 2019-10-02 | 2020-10-02 | Zinc finger protein transcription factors for repressing alpha-synuclein expression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL291827A true IL291827A (en) | 2022-06-01 |
Family
ID=73014653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL291827A IL291827A (en) | 2019-10-02 | 2022-03-30 | Zinc finger protein transcription factors to suppress alpha-synuclein expression |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220324928A1 (enExample) |
| EP (1) | EP4041754A1 (enExample) |
| JP (1) | JP2022551286A (enExample) |
| KR (1) | KR20220071248A (enExample) |
| CN (1) | CN114466867A (enExample) |
| AU (1) | AU2020356962B2 (enExample) |
| CA (1) | CA3156258A1 (enExample) |
| IL (1) | IL291827A (enExample) |
| TW (2) | TWI888417B (enExample) |
| WO (1) | WO2021067871A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4731643A2 (en) * | 2023-06-26 | 2026-04-29 | Navega Therapeutics, Inc. | Compositions and methods for reducing pain and inflammation through epigenetic modulation |
| WO2025264967A1 (en) * | 2024-06-21 | 2025-12-26 | The Johns Hopkins University | Agents and/or compositions useful for modulating cis-regulatory elements in synucleinopathies and methods for identifying agents and compositions thereof |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5420032A (en) | 1991-12-23 | 1995-05-30 | Universitge Laval | Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence |
| US5792632A (en) | 1992-05-05 | 1998-08-11 | Institut Pasteur | Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
| US6140466A (en) | 1994-01-18 | 2000-10-31 | The Scripps Research Institute | Zinc finger protein derivatives and methods therefor |
| JP4012243B2 (ja) | 1994-01-18 | 2007-11-21 | ザ スクリップス リサーチ インスティチュート | 亜鉛フィンガータンパク質誘導体およびそのための方法 |
| GB9824544D0 (en) | 1998-11-09 | 1999-01-06 | Medical Res Council | Screening system |
| CA2196419C (en) | 1994-08-20 | 2007-08-21 | Yen Choo | Improvements in or relating to binding proteins for recognition of dna |
| GB9710809D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| GB9710807D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| DE69942334D1 (de) | 1998-03-02 | 2010-06-17 | Massachusetts Inst Technology | Poly-zinkfinger-proteine mit verbesserten linkern |
| US7030215B2 (en) * | 1999-03-24 | 2006-04-18 | Sangamo Biosciences, Inc. | Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| US20020061512A1 (en) | 2000-02-18 | 2002-05-23 | Kim Jin-Soo | Zinc finger domains and methods of identifying same |
| AU2001263155A1 (en) | 2000-05-16 | 2001-11-26 | Massachusetts Institute Of Technology | Methods and compositions for interaction trap assays |
| JP2002060786A (ja) | 2000-08-23 | 2002-02-26 | Kao Corp | 硬質表面用殺菌防汚剤 |
| US20050235369A1 (en) * | 2001-03-28 | 2005-10-20 | Yen Choo | Gene regulation II |
| GB0108491D0 (en) | 2001-04-04 | 2001-05-23 | Gendaq Ltd | Engineering zinc fingers |
| CA2442670A1 (en) * | 2001-04-13 | 2002-10-24 | The Trustees Of The University Of Pennsylvania | Method of treating or retarding the development of blindness |
| US20040224385A1 (en) | 2001-08-20 | 2004-11-11 | Barbas Carlos F | Zinc finger binding domains for cnn |
| US7595306B2 (en) * | 2003-06-09 | 2009-09-29 | Alnylam Pharmaceuticals Inc | Method of treating neurodegenerative disease |
| WO2005004794A2 (en) * | 2003-06-09 | 2005-01-20 | Alnylam Pharmaceuticals Inc. | Method of treating neurodegenerative disease |
| AU2005233583B2 (en) * | 2004-04-08 | 2011-02-03 | Sangamo Therapeutics, Inc. | Methods and compositions for modulating cardiac contractility |
| DK3246403T3 (da) | 2005-10-18 | 2020-10-26 | Prec Biosciences | Rationelt designede meganucleaser med ændret sekvens-specificitet og dna-bindende affinitet |
| AU2009212247A1 (en) * | 2008-02-08 | 2009-08-13 | Sangamo Therapeutics, Inc. | Treatment of chronic pain with zinc finger proteins |
| EP2566972B1 (en) | 2010-05-03 | 2020-01-15 | Sangamo Therapeutics, Inc. | Compositions for linking zinc finger modules |
| WO2012094132A1 (en) * | 2011-01-05 | 2012-07-12 | Sangamo Biosciences, Inc. | Methods and compositions for gene correction |
| BR112014020325A2 (pt) * | 2012-02-17 | 2017-08-08 | Childrens Hospital Philadelphia | composições de vetor do aav e métodos para a transferência de gene para as células, órgãos e tecidos |
| IL264792B2 (en) | 2016-08-24 | 2023-10-01 | Sangamo Therapeutics Inc | Engineered target-specific zinc-finger nucleases |
| CN110214184B (zh) * | 2016-12-01 | 2024-07-02 | 桑格摩生物治疗股份有限公司 | τ蛋白调节剂以及用于其递送的方法和组合物 |
| WO2019152433A1 (en) * | 2018-01-30 | 2019-08-08 | Parkinson's Institute | Crispr-based downregulation of alpha-synuclein expression as a novel parkinson's disease therapeutic |
| US20190345516A1 (en) * | 2018-03-12 | 2019-11-14 | Musc Foundation For Research Development | Methods for treating eye disease |
| TW202134288A (zh) * | 2020-01-22 | 2021-09-16 | 美商聖加莫治療股份有限公司 | 用於抑制tau蛋白表現之鋅指蛋白轉錄因子 |
-
2020
- 2020-10-02 WO PCT/US2020/054148 patent/WO2021067871A1/en not_active Ceased
- 2020-10-02 KR KR1020227014231A patent/KR20220071248A/ko active Pending
- 2020-10-02 JP JP2022520779A patent/JP2022551286A/ja not_active Ceased
- 2020-10-02 AU AU2020356962A patent/AU2020356962B2/en active Active
- 2020-10-02 CA CA3156258A patent/CA3156258A1/en active Pending
- 2020-10-02 CN CN202080069917.0A patent/CN114466867A/zh active Pending
- 2020-10-02 US US17/766,076 patent/US20220324928A1/en active Pending
- 2020-10-02 EP EP20797308.2A patent/EP4041754A1/en active Pending
- 2020-10-05 TW TW109134486A patent/TWI888417B/zh active
- 2020-10-05 TW TW114122441A patent/TW202539725A/zh unknown
-
2022
- 2022-03-30 IL IL291827A patent/IL291827A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021067871A1 (en) | 2021-04-08 |
| AU2020356962A1 (en) | 2022-04-14 |
| AU2020356962B2 (en) | 2026-08-06 |
| US20220324928A1 (en) | 2022-10-13 |
| EP4041754A1 (en) | 2022-08-17 |
| TWI888417B (zh) | 2025-07-01 |
| CA3156258A1 (en) | 2021-04-08 |
| WO2021067871A9 (en) | 2021-05-06 |
| KR20220071248A (ko) | 2022-05-31 |
| TW202126681A (zh) | 2021-07-16 |
| TW202539725A (zh) | 2025-10-16 |
| CN114466867A (zh) | 2022-05-10 |
| AU2020356962A9 (en) | 2026-07-30 |
| JP2022551286A (ja) | 2022-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA195576S (en) | Inhaler | |
| GB202007441D0 (en) | Polypeptide | |
| IL288412A (en) | peptides | |
| IL289264A (en) | Variable geometry cannula | |
| GB202009824D0 (en) | Inhaler | |
| EP3987028A4 (en) | MANIPULATED ONCOSELECTIVE PROTEIN EXPRESSION | |
| EP3912029C0 (en) | ADAPTIVE USER INTERFACES FOR COMPUTER-ASSISTED TECHNOLOGY APPLICATIONS | |
| GB201810937D0 (en) | Magnetic finger nails | |
| HK40080934A (en) | Zinc finger protein transcription factors for repressing alpha-synuclein expression | |
| GB2590277B (en) | Speech recognition | |
| PL4076605T3 (pl) | Inhalator | |
| HK40098722A (en) | Novel zinc finger protein transcription factors for repressing alpha-synuclein expression | |
| GB201913747D0 (en) | Turbocharger | |
| EP3770260A4 (en) | RECOMBINANT PRO-ACTIVIN A PROTEIN | |
| GB202117583D0 (en) | Protein expression | |
| HK40084794A (en) | Zinc finger protein transcription factors for repressing tau expression | |
| HK40080933A (en) | Zinc finger protein transcription factors for treatment of prion disease | |
| GB202015059D0 (en) | Masc | |
| HK40054987A (en) | Variant rnai against alpha-synuclein | |
| GB202113858D0 (en) | Peptides | |
| GB202101825D0 (en) | Protein | |
| GB202101828D0 (en) | Protein | |
| GB202101826D0 (en) | Protein | |
| GB202110693D0 (en) | Peptides | |
| HK40073758A (en) | Engineered oncoselective protein expression |